(Q53120477)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27086658%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

title

Autoimmune dermatologic toxicities from immune checkpoint blockade with anti-PD-1 antibody therapy: a report on bullous skin eruptions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27086658%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference

Priyadharsini Nagarajan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27086658%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

George Jour

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27086658%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Phyu Phyu Aung

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27086658%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

author name string

Isabella C Glitza

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27086658%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Rachel M Ellis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27086658%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Carlos A Torres-Cabala

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27086658%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Michael T Tetzlaff

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27086658%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Janet Y Li

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27086658%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Auris Huen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27086658%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Doina Ivan

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27086658%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Carol R Drucker

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27086658%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Victor G Prieto

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27086658%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Ronald P Rapini

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27086658%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Anisha Patel

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27086658%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Jonathan L Curry

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27086658%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

publication date

8 May 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27086658%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cutaneous Pathology

2 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27086658%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27086658%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27086658%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

page(s)

688-696

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27086658%20AND%20SRC:MED&resulttype=core&format=json

Pembrolizumab versus Ipilimumab in Advanced Melanoma

2 April 2020

cites work

1 reference

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

21 January 2018

1 reference

Immune checkpoint blockade in cancer treatment: a double-edged sword cross-targeting the host as an "innocent bystander".

21 January 2018

1 reference

Risk of cutaneous toxicities in patients with solid tumors treated with immune checkpoint inhibitors: a meta-analysis.

21 January 2018

1 reference

Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression.

21 January 2018

1 reference

Acute skin reaction suggestive of pembrolizumab-induced radiosensitization.

21 January 2018

1 reference

A case of bullous pemphigoid in a patient with metastatic melanoma treated with pembrolizumab.

21 January 2018

1 reference

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

21 January 2018

1 reference

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.

21 January 2018

1 reference

Bullous pemphigoid: associations and management guidelines: facts and controversies

21 January 2018

1 reference

Bullous pemphigoid: etiology, pathogenesis, and inducing factors: facts and controversies.

21 January 2018

1 reference

Skin biopsy: Biopsy issues in specific diseases

21 January 2018

1 reference